Characteristics of Interstitial Fibrosis and Inflammatory Cell Infiltration in Right Ventricles of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension

被引:62
|
作者
Overbeek, Maria J. [1 ]
Mouchaers, Koen T. B. [1 ]
Niessen, Hans M. [2 ,3 ]
Hadi, Awal M. [1 ]
Kupreishvili, Koba [2 ]
Boonstra, Anco [1 ]
Voskuyl, Alexandre E. [4 ]
Belien, Jeroen A. M. [2 ]
Smit, Egbert F. [1 ]
Dijkmans, Ben C. [4 ]
Vonk-Noordegraaf, Anton [1 ]
Grunberg, Katrien [2 ]
机构
[1] Vrije Univ Amsterdam, VU Univ Med Ctr, Dept Pulm Dis, Boelelaan 1117, NL-1007 MB Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, VU Univ Med Ctr, Dept Pathol, NL-1007 MB Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, VU Univ Med Ctr, Dept Cardiac Surg, NL-1007 MB Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, VU Univ Med Ctr, Dept Rheumatol, NL-1007 MB Amsterdam, Netherlands
关键词
D O I
10.1155/2010/604615
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Systemic sclerosis-associated pulmonary arterial hypertension (SScPAH) has a disturbed function of the right ventricle (RV) when compared to idiopathic PAH (IPAH). Systemic sclerosis may also affect the heart. We hypothesize that RV differences may occur at the level of interstitial inflammation and-fibrosis and compared inflammatory cell infiltrate and fibrosis between the RV of SScPAH, IPAH, and healthy controls. Methods. Paraffin-embedded tissue samples of RV and left ventricle (LV) from SScPAH (n = 5) and IPAH (n = 9) patients and controls (n = 4) were picrosirius red stained for detection of interstitial fibrosis, which was quantified semiautomatically. Neutrophilic granulocytes (MPO), macrophages (CD68), and lymphocytes (CD45) were immunohistochemically stained and only interstitial leukocytes were counted. Presence of epi-or endocardial inflammation, and of perivascular or intimal fibrosis of coronary arteries was assessed semiquantitatively (0-3: absent to extensive). Results. RV's of SScPAH showed significantly more inflammatory cells than of IPAH (cells/mm(2), mean +/- sd MPO 11 +/- 3 versus 6 +/- 1; CD68 11 +/- 3 versus 6 +/- 1; CD45 11 +/- 1 versus 5 +/- 1, P < .05) and than of controls. RV interstitial fibrosis was similar in SScPAH and IPAH (4 +/- 1 versus 5 +/- 1%, P = .9), and did not differ from controls (5 +/- 1%, P = .8). In 4 SScPAH and 5 IPAH RV's foci of replacement fibrosis were found. No differences were found on epi-or endocardial inflammation or on perivascular or intimal fibrosis of coronary arteries. Conclusion. SScPAH RVs display denser inflammatory infiltrates than IPAH, while they do not differ with respect to interstitial fibrosis. Whether increased inflammatory status is a contributor to altered RV function in SScPAH warrants further research.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Right Ventricular Function in Systemic Sclerosis-associated Pulmonary Arterial Hypertension
    Koestenberger, Martin
    Ravekes, William
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (01) : 90 - 91
  • [2] Right Ventricular Dysfunction in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
    Tedford, Ryan J.
    Mudd, James O.
    Girgis, Reda E.
    Mathai, Stephen C.
    Zaiman, Ari L.
    Housten-Harris, Traci
    Boyce, Danielle
    Kelemen, Benjamin W.
    Bacher, Anita C.
    Shah, Ami A.
    Hummers, Laura K.
    Wigley, Fredrick M.
    Russell, Stuart D.
    Saggar, Rajeev
    Saggar, Rajan
    Maughan, W. Lowell
    Hassoun, Paul M.
    Kass, David A.
    CIRCULATION-HEART FAILURE, 2013, 6 (05) : 953 - 963
  • [3] Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
    Chaisson, Neal F.
    Hassoun, Paul M.
    CHEST, 2013, 144 (04) : 1346 - 1356
  • [4] Systemic Sclerosis-associated Pulmonary Arterial Hypertension
    Le Payec, Jerome
    Humbert, Marc
    Mouthon, Luc
    Hassoun, Paul M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181 (12) : 1285 - 1293
  • [5] INCREASED INTERSTITIAL INFLAMMATORY CELL INFILTRATION, BUT NOT FIBROSIS, IN RIGHT VENTRICLES OF SSC-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION (PAH) VS. IDIOPATHIC PAH
    Overbeek, M.
    Mouchaers, K.
    Niessen, H.
    Kupreishvili, K.
    Boonstra, A.
    Vosjuyl, A.
    Belien, J.
    Smit, E.
    Dijkmans, B.
    Noordegraaf, A. Vonk
    Grunberg, K.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S126 - S126
  • [6] Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension
    Overbeek, M. J.
    Lankhaar, J-W.
    Westerhof, N.
    Voskuyl, A. E.
    Boonstra, A.
    Bronzwaer, J. G. F.
    Marques, K. M. J.
    Smit, E. F.
    Dijkmans, B. A. C.
    Vonk-Noordegraaf, A.
    EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (06) : 1160 - 1166
  • [7] Right Ventricular Function in Systemic Sclerosis-associated Pulmonary Arterial Hypertension Reply
    Mathai, Stephen C.
    Hassoun, Paul M.
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (01) : 91 - 91
  • [8] Systemic sclerosis-associated pulmonary arterial hypertension in children
    Apitz, Christian
    Girschick, Hermann
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2021, 11 (04) : 1137 - 1143
  • [9] Update in systemic sclerosis-associated pulmonary arterial hypertension
    Gashouta, Mohamed A.
    Humbert, Marc
    Hassoun, Paul M.
    PRESSE MEDICALE, 2014, 43 (10): : E293 - E304
  • [10] Bosentan for the treatment of systemic sclerosis-associated pulmonary arterial hypertension, pulmonary fibrosis and digital ulcers
    Jain, Manu
    Varga, John
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (11) : 1487 - 1501